Epidemiological and bacteriological profiles in children with burns

Burns. 2014 Aug;40(5):1040-5. doi: 10.1016/j.burns.2013.10.020. Epub 2013 Dec 9.

Abstract

Objectives: The aim of our study is to determine the most prevalent bacteria responsible for nosocomial infection (NI) in burned children.

Materials and methods: A prospective analytic study was conducted over a period of 30 months at the Children's Hospital of Tunisia. All burned children were enrolled.

Results: A total of 185 children were hospitalised during the study period. The mean age was 30 months (interquartile range, IR:18; 48). The gender ratio of the study population was 1.3 (104 males and 81 females). The mean total body surface area burned (TBSA) was 10% (IR:6; 16). The incidence rate of NI was 39.1 NIs per 1000 patient-days and two-thirds of the infections were polymicrobial. The most common isolated micro-organisms were methicillin-susceptible Staphylococcus aureus (MSSA, 57.7%), wild-type Pseudomonas aeruginosa (35.9%) and wild-type Enterobacter cloacae (26.9%). The case fatality rate was 5.9% corresponding to a crude death rate of 1.32 deaths per year. Septic shock with multiple organ failure was the leading cause of death.

Conclusion: The most common micro-organisms responsible for NI in our series were of the wild-type phenotype. Thus, on suspicion of sepsis, empiric antibiotic treatment combining piperacillin, oxacillin and gentamicin can be proposed until identification of the causative microorganism is available.

Keywords: Bacteria; Burn; Children; Infection.

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Burns / epidemiology*
  • Child
  • Child, Preschool
  • Cohort Studies
  • Cross Infection / drug therapy
  • Cross Infection / epidemiology*
  • Cross Infection / microbiology
  • Drug Resistance, Bacterial
  • Enterobacter cloacae
  • Enterobacteriaceae Infections / drug therapy
  • Enterobacteriaceae Infections / epidemiology*
  • Female
  • Gentamicins / therapeutic use
  • Humans
  • Male
  • Oxacillin / therapeutic use
  • Piperacillin / therapeutic use
  • Prospective Studies
  • Pseudomonas Infections / drug therapy
  • Pseudomonas Infections / epidemiology*
  • Pseudomonas aeruginosa
  • Sepsis / drug therapy
  • Sepsis / epidemiology*
  • Sepsis / microbiology
  • Staphylococcal Infections / drug therapy
  • Staphylococcal Infections / epidemiology*
  • Staphylococcus aureus
  • Wound Infection / drug therapy
  • Wound Infection / epidemiology*
  • Wound Infection / microbiology

Substances

  • Anti-Bacterial Agents
  • Gentamicins
  • Oxacillin
  • Piperacillin